PROVIDER PROFILE · NPI 1306008552

Marvin Delgado-GuayMD

PRESCRIBING · PART D · 2024
Total Rx claims
402
Beneficiaries
Total drug cost
$10K
Distinct drugs
12
Brand share
16.2%
Top prescribed drugs
QUALITY · MIPS · 2024
Final MIPS score
84.3
Quality
70.8
Cost
67.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.39%
Group
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

Hospital